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Experimental evidence suggests that the prokaryotic respiratory cytochrome bd quinol oxidase is
responsible for both bioenergetic functions and bacterial adaptation to different stress conditions.
The enzyme, phylogenetically unrelated to the extensively studied heme–copper terminal oxidases,
is found in many commensal and pathogenic bacteria. Here, we review current knowledge on the
catalytic intermediates of cytochrome bd and their reactivity towards nitric oxide (NO). Available
information is discussed in the light of the hypothesis that, owing to its high NO dissociation rate,
cytochrome bd confers resistance to NO-stress, thereby providing a strategy for bacterial pathogens
to evade the NO-mediated host immune attack.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Cytochrome bd [1–3] is a respiratory terminal oxidase widely
distributed among prokaryotes (Eubacteria and Archaea), not yet
found in eukaryotic organisms. Identiﬁed more than 80 years ago
[4], its impact on cell physiology is still not completely understood,
which makes this respiratory enzyme an attractive system to be
investigated. Beyond its role in energy metabolism, a large body
of evidence suggests that the enzyme plays alternative functions
relevant to physiology and, more speciﬁcally, to bacterial adapta-
tion to a wide variety of stress conditions [3,5]. This respiratory
oxidase has been identiﬁed in a number of pathogens [6–15]
and, in some cases, its expression level was intriguingly found toal Societies. Published by Elsevier
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. Giuffrè).positively correlate with virulence. Evidence suggests that
cytochrome bd is implicated in adaptation to the hostile conditions
created by host immunity during the infection process, though the
molecular mechanism(s) through which the enzyme operates to
enhance bacterial resistance have been only partly clariﬁed.
Cytochrome bd shows no sequence homology with the exten-
sively studied heme–copper oxidases (HCOs) [16–19]. Compared
to these latter oxidases, it exhibits interesting similarities at the
level of the catalytic mechanism (see below), but also some charac-
teristic peculiarities. While HCOs invariantly comprise a high spin
heme iron (heme a3, o3 or b3) and a copper metal (CuB) in the active
site, cytochrome bd does not have a copper cofactor, but only three
hemes. Both HCOs and cytochrome bd catalyze the complete, four-
electron reduction of O2 to H2O; cytochrome bd, however, can only
use quinols as natural reducing substrates [2], whereas the large
superfamily of HCOs comprises both cytochrome c- and quinol-
oxidases [17]. HCOs and cytochromes bd are characterized by dis-
tinct energetic efﬁciencies. The overall reaction catalyzed by most
cytochromes bd is indeed electrogenic [20], leading to proton
motive force generation, but contrary to HCOs, is not associated
to proton pumping [21], thereby resulting in a lower efﬁciency.B.V. Open access under CC BY-NC-ND license. 
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ide (nitric oxide, NO) plays a key role in a wide range of physiolog-
ical and pathological processes, such as vasodilation, platelet
aggregation, neuromodulation, cell death and host immunity. Over
and above these functions, NO is also a potent inhibitor of HCOs
(reviewed in [22–25]). Extensive studies on mitochondrial
cytochrome c oxidase (CcO) proved that the enzyme is promptly
inhibited by relatively low NO concentrations, even in the presence
of an excess of O2. Inhibition is reversible and, accordingly, the
O2-reductase activity is completely restored if NO in solution van-
ishes by reacting with O2 or scavenging systems (like oxygenated
myoglobin/hemoglobin). Interestingly, the transient NO-inhibition
of mitochondrial respiration at CcO has been suggested to control
several important physiological processes (reviewed in [24–27]),
including ATP synthesis, extra-mitochondrial O2-dependent
enzymatic reactions, tissue oxygenation, reactive oxygen species
mitochondrial production and cell signalling.
CcO is inhibited by NO according to two different pathways
[22–25]. NO can either bind to ferrous heme a3 in the active site,
yielding a stable nitrosyl adduct, or it can generate a nitrite-bound
ferric heme a3 adduct, by reacting with enzyme species containing
fully oxidized heme a3/CuB or ferryl heme a3. In the latter case
(nitrite pathway), NO was proposed to react with oxidized CuB
leading to the transient formation of nitrosonium ion (NO+), subse-
quently converted into nitrous acid/nitrite by hydroxylation [28–
31]. The O2-competitive nitrosyl pathway prevails at higher elec-
tron ﬂux and lower O2 concentration, whereas the nitrite pathway
at lower electron ﬂux and higher O2 concentration [32]. In the for-
mer case, inhibition is persistent and, in the absence of free NO in
solution, reverts at the low rate of NO dissociation form ferrous
heme a3 (k = 0.0035 s1 at 20 C, [32], see Table 1). Conversely, in
the latter case, if NO in solution is exhausted, activity is promptly
recovered following the fast nitrite ejection from heme a3 upon
reduction of this site [33].
In their natural habitat prokaryotes often encounter the NO
produced from abiotic or biotic sources. Particularly, host infect-
ing bacteria are challenged by the NO and related reactive species
(collectively termed ‘reactive nitrogen species’) that are produced
as part of the immune response to control microbial proliferation.
Consistently, during evolution infectious microorganisms haveTable 1
Rate constants for the reactions of reduced CcO or cytochrome bd with O2, CO and NO.
Beef heart cytochrome c oxidase Cytochrom
O2 CO NO O2
R4 R4 R4 R1
kon (M1 s1) 1.3  108a 8.0  104b 1.0  108c
koff (s1) 0.023b 0.0035d 78e
Kd (nM) 300n 0.2n 280p
1 The values relative to the A. vinelandii cytochrome bd are depicted in bold.
a [97].
b [83].
c [98].
d [32].
e [58].
f [99].
g [54].
h [51].
i [52].
l [59].
m [49].
n [76].
p [57].
q [63].
r [77].developed systems to detoxify NO and survive nitrosative stress.
NO detoxiﬁcation in microbes is mainly accomplished by en-
zymes endowed with NO-reductase or NO-dioxygenase (O2-deni-
trosylase) activity, such as the NO-reductase ﬂavorubredoxin
[34,35] and the ﬂavohemoglobin [36,37] in Escherichia coli. NO-
reductases anaerobically reduce NO to dinitrogen oxide (N2O),
while NO-dioxygenases aerobically degrades NO to nitrate
(NO3 ). Under aerobic conditions, ﬂavohemoglobin scavenges NO
with high efﬁcacy, but the catalytic activity of the enzyme is
characterized by a relatively low apparent afﬁnity for O2
(KM  20–100 lM O2, [38,39]).
Given the wide distribution of cytochrome bd in prokaryotes
and its occurrence in several bacterial pathogens, recent studies
aimed at investigating the reactivity of NO with this respiratory
oxidase in order to assess its relevance to microbial physiology.
The results from these studies are reviewed here in the light of
the proposal that physiologically cytochrome bd can enhance bac-
terial tolerance to nitrosative stress, thereby promoting
pathogenicity.
2. Catalytic intermediates
The three-dimensional structure of cytochrome bd is yet un-
known. The enzyme is a heterodimer of two integral membrane
polypeptides, subunits I and II, carrying three heme cofactors:
the low spin hexacoordinate heme b558 and the high spin pentaco-
ordinate hemes b595 and d [40] (Fig. 1). Heme b558 in subunit I rep-
resents the site of quinol oxidation, whereas heme d is the site
where O2 chemistry takes place. Conversely, the function of heme
b595 is not yet fully understood. This redox site has been proposed
to form together with heme d a bimetallic active site [41–49], thus
functionally mimicking CuB in HCO. Beta-lactamase gene fusion
experiments showed that all three hemes are likely located near
the periplasmic space [50]. Based on this topology, membrane po-
tential generation by cytochrome bd is expected to primarily result
from proton transfer from the cytoplasm to the enzyme active site
on the opposite side of the membrane, rather than from inter-
heme electron transfer.
Insights into the catalytic intermediates of cytochrome bd were
obtained by ﬂow-ﬂash investigation of the reaction of the fullye bd from E. coli or A. vinelandii1
CO NO
R3 R1 R3 R1 R3
0.3  109f 1.0  108l 1.5  108l
2.0  109g 0.8  108h,m
2.0  109h
1.9  109i
4.2e 6.0e 0.036e 0.133e
80q 0.55r
Fig. 2. Suggested catalytic cycle. The heme redox state in each intermediate is
denoted by closed (Fe2+) or open (Fe3+) symbols. In the F intermediate, heme d is in
the Fe4+ redox state. The intermediates detected at steady-state [60] are high-
lighted. The fully ferric (O) species was suggested not to be an intermediate of the
catalytic cycle [61]. Contrary to the four-electron reduced CcO, in the absence of
exogenous reducing equivalents, the three-electron reduced cytochrome bd (R) by
reacting with O2 yields the F intermediate as the ﬁnal species [20].
Fig. 1. Schematic representation of cytochrome bd. Electrons donated by quinols
are transferred from heme b558 to heme d where the O2 chemistry takes place. The
function of heme b595 is still debated. The reaction is electrogenic, but not coupled
to proton pumping.
Fig. 3. Catalytic intermediates detected at steady-state. Panel A: Reference optical
spectra (normalized to 1 lM enzyme): ‘b5583+’ = [Feb5583+]  [Feb5582+];
‘b5953+’ = [Feb5953+]  [Feb5952+]; ‘O’ = [Fed3+]  [Fed2+]; ‘F’ = [Fed4+ = O2]  [Fed2+];
‘A’ = [Fed2+–O2]  [Fed2+]. Panel B: Fractional occupancy of the optical species
depicted in (A) as obtained from deconvolution analysis of the time-resolved
spectra collected after stopped-ﬂow mixing 20 lM enzyme (pre-reduced with
10 mM DTT and 600 lM Q1) with O2-equilibrated buffer (see [60] for details).
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the reaction was monitored by spectroscopic or electrometric tech-
niques [20,41,51–53], following laser photolysis of the carbon mon-
oxide (CO)-bound R3 enzyme in the presence of O2. These
measurements show that cytochrome bd and HCOs share similarities
at the level of their catalytic intermediates (Fig. 2). Likewise CcO and
other HCOs, the ﬁrst intermediate detectable after CO-photolysis is
the so-called compound A (A3 in Fig. 2), i.e., the R3 enzyme with
O2 bound to ferrous heme d. Formation of A3 was shown to occur
at high rates (kon  2  109 M1 s1 [51,52,54]) without generating
electric potential [20,52]. Afterwards, a rapid (s = 4.5 ls), non-elec-
trogenic oxidation of heme b595 was observed and the resulting spe-
cies was suggested to be a peroxy intermediate (P) [52,53]. Notably,
in the reaction of CcO with O2 such an intermediate is not populated
at detectable levels, as it rapidly converts to a ferryl species, that
anyway for historical reasons was named ‘P’ (as incorrectly assigned1 The superscript number denotes the total number of electrons in the enzyme
species.to a peroxo-species) (see [55] and references therein). In the absence
of exogenous electron equivalents, as the ﬁnal step in the reaction,
heme b558 in cytochrome bd is oxidized and the ferryl (F) intermedi-
ate is populated with s = 47 ls. This last P?F transition is electro-
genic [20,41,52,53]. In enzyme preparations with bound quinol, an
additional electrogenic phase was observed with s = 0.6–1.1 ms
[41,52], assigned to the conversion of F into the oxidized enzyme
(O) or, more likely, into the single-electron reduced, oxygenated en-
zyme (A1), since quinol can act as a two-electron donor.
Owing to the high afﬁnity of heme d2+ for O2 [54,56,57], the A1
species of cytochrome bd with ferrous-oxy heme d is stable so that
a considerable fraction of the enzyme is isolated in such a state
[54,56,57]. The high stability of A1 is a peculiarity of cytochrome
bd. This species was not observed in HCOs, to which O2 can only
bind at the heme–copper binuclear site in the two-electron re-
duced state. The rate of O2 binding to R1 cytochrome bd
(b5583+b5953+ d2+) was directly measured by ﬂow-ﬂash and found
to hyperbolically depend on O2 concentration [54]. In contrast
the R3 enzyme binds O2 with rates linearly dependent on O2 con-
centration [54], as expected for a simple bimolecular process as-
sayed under pseudo-ﬁrst order conditions. The saturation kinetic
behaviour observed with R1, but not with R3, was tentatively ex-
plained by assuming that in the R1 enzyme two conformations,
one O2-accessible (‘open’) and the other O2-inaccessible (‘closed’),
co-exist in equilibrium [54]. Consistently, also in the case of CO,Colour code as in (A). Please notice that part of the reaction of the reduced enzyme
with O2 is lost in the dead-time of the stopped-ﬂow apparatus, followed by an
oxidation phase (<100 ms), a steady-state phase (up to 100 s) and after O2
exhaustion a reduction phase eventually restoring the fully reduced enzyme.
Fig. 4. Reactions of heme d with NO. According to [58,79], the reaction of NO with ferrous or ferryl heme d is fast and yields a nitrosyl ferrous (Fe2+–NO) or a nitrite-ferric
(Fe3+–NO2) derivative, respectively. A nitrosyl ferric (Fe3+–NOMFe2+–NO+) adduct was instead suggested to form upon reaction of ferric heme d with NO [82].
2 In addition to the heme-copper cytochrome bo3 quinol oxidase, E. coli possesses
two bd-type oxidases, called bd-I and bd-II. Unless otherwise stated, we refer to
cytochrome bd-I throughout the manuscript.
A. Giuffrè et al. / FEBS Letters 586 (2012) 622–629 625higher on- and off-rates were measured for the R3 cytochrome bd,
as compared to the R1 enzyme [49,51,58,59] (see Table 1). Ligand
binding properties of heme d are therefore clearly inﬂuenced by
the redox state of the heme(s) b, but the structural determinants
of this redox control remain elusive.
Recently, the steady-state occupancy of the cytochrome bd
catalytic O2 intermediates during turnover was measured by
stopped-ﬂow multiwavelength absorption spectroscopy [60],
taking advantage from the fact that the O2-reactive heme d absorbs
in the visible region at wavelengths (>600 nm), where the spectral
contributions of the hemes b558 and b595 are minor (Fig. 3A). In that
study, time-resolved absorption spectra were collected after
rapidly mixing reduced cytochrome bd with O2-equilibrated buffer
in the presence of excess DTT (dithiothreitol) and Q1 (2,3-
dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone).
Global analysis of the spectral data showed that the ferryl (F) and
oxy-ferrous (A) species are the mostly populated catalytic interme-
diates at steady-state, with a residual minor fraction of the enzyme
containing ferric (O) heme d and possibly one electron on heme
b558 (Fig. 3B). This is in line with the proposal that the fully ferric
species is not an intermediate of the catalytic cycle [61] (see
Fig. 2). These results obtained with cytochrome bd differ from
those obtained under similar conditions with CcO, using cyto-
chrome c as the reducing substrate, where the steady-state occu-
pancy of the oxygen catalytic intermediates was reportedly very
low (<10%, [62]).
3. Reactions with nitric oxide
In the Cu-lacking bd-type oxidases, NO, as CO [63] and O2
[54,57], binds to ferrous heme d with high afﬁnity [64,65]
(Fig. 4). Formation of the resulting nitrosyl adduct is accompanied
by characteristic changes in the UV–visible absorption and electron
paramagnetic resonance (EPR) spectra of the enzyme [64,65]. At
low concentrations, NO almost exclusively binds to heme d2+,
whereas at high concentrations low-afﬁnity NO binding to heme
b595 [64,65] or heme b558 [46] was suggested too. The yet unknown
rate of NO binding to the ferrous uncomplexed heme d is expected
to be very high, and possibly comparable to that of O2
(kon  2  109 M1 s1 for R3 [51,52,54]). The reaction of NO with
oxy-ferrous heme d (Fe2+–O2) in the A1 enzyme also results ulti-
mately in formation of the nitrosyl heme d adduct after displace-
ment of the O2 bound, but in this case NO binding is limited by
the off-rate of O2 from the reduced heme (k = 78 s1 at 20 C,
[58]) (Fig. 4).Some bacterial HCOs [66–68], but not mitochondrial CcO [69],
under anaerobic conditions exhibit a low NO-reductase activity,
yielding N2O as the ﬁnal product. This result is perhaps not surpris-
ing, since HCOs are believed to share a common phylogenesis with
heme b3-containing bacterial NO-reductases [70,71]. Since the
ability of some HCOs to function as NO-reductases was tentatively
attributed to structural and/or functional peculiarities at the level
of CuB [66], the lack of this metal in cytochrome bd raised the ques-
tion as to whether the enzyme is capable of reductively metabolis-
ing NO to N2O. Making use of a selective NO electrode,
amperometric measurements carried out on cytochrome bd puri-
ﬁed from Escherichia coli2 or Azotobacter vinelandii clearly showed
that neither of these two Cu-lacking oxidases is endowed with a
measurable NO reductase activity [72]. Based on this ﬁnding, one
may conclude that the presence of a non-heme metal in the active
site (copper in HCO or iron in bacterial NO-reductase) is a pre-
requisite for reduction of NO; more recently, however, coordination
of NO to CuB was proposed to be a dispensable step in the mecha-
nism of NO reduction by HCOs [73].
Similarly to CcO, cytochrome bd is inhibited by NO. First evi-
dence for this was provided by measuring the NO-sensitivity of
cytochrome bd-mediated respiration by E. coli mutant cells lacking
the alternative heme–copper cytochrome bo3 quinol oxidase [74].
In agreement with these measurements, in the presence of DTT
and Q1, the O2 consumption catalyzed by cytochrome bd isolated
from E. coli or A. vinelandii is rapidly inhibited upon addition of rel-
atively low amounts (61 lM) of NO [72]. Possibly relevant to
microbial physiology, the degree of inhibition depends on the O2
concentration, the inhibition being more potent at lower [O2].
The IC50 value for E. coli cytochrome bd inhibition by NO
(100 ± 34 nM at 70 lM O2 [72]) is not very different from that re-
ported for CcO [75,76], and proved to be linearly dependent on [O2]
(at least up to 150 lM O2) in experiments carried out on cyto-
chrome bo3-lacking E. coli cells [77]. Interestingly, based on this
information, inhibition of cytochrome bd is likely to occur in vivo
during bacterial infection, when oxygen concentration is quite
low and lM NO is produced by immunocompetent cells to coun-
teract microbial proliferation.
All together, the studies mentioned above demonstrate that the
presence of CuB is not essential for terminal oxidases inhibition by
NO. The question arising is: what is the exact mechanism whereby
626 A. Giuffrè et al. / FEBS Letters 586 (2012) 622–629cytochrome bd in turnover with O2 is inhibited by NO? One may
speculate that inhibition proceeds through the reaction of NO with
enzyme species containing ferrous uncomplexed heme d, owing to
its high ligand binding afﬁnity; heme d2+ can indeed be targeted by
both O2 and NO and this reasonably accounts for the observed
O2-competitive nature of NO-inhibition [72,77]. On the other hand,
the fast inhibition of the enzyme observed at low NO concentra-
tions (61 lM) even in the presence of a large excess of O2
(100–200 lM), commonly observed also with CcO, is somewhat
puzzling. At this low NO/O2 ratio, if NO was reacting solely with
ferrous uncomplexed heme d, accumulation of the inhibited en-
zyme should be slower than observed; NO binding to heme d2+
would indeed be kinetically outcompeted by the O2 present in
large molar excess, since both ligands are expected to react with
heme d2+ with similar second order rate constants. To account
for this discrepancy, one may hypothesize that, similarly to CcO,
the enzyme in turnover populates catalytic intermediates (without
ferrous uncomplexed heme d2+) that, in spite of their low or even
absent reactivity towards O2, are promptly targeted by NO leading
to enzyme inhibition.
The hypothesis seems tenable, because we now know that the
mostly populated catalytic intermediates at steady-state, the
oxy-ferrous (A) and ferryl (F) intermediates [60], clearly O2-unre-
active, can both react with NO, though each one according to a dif-
ferent reaction pathway (Fig. 4). As mentioned above, reaction of
A1 with NO ends-up with formation of the heme–NO adduct at a
rate-limiting value of 78 s1 assigned to the koff of O2 from the re-
duced heme d [58]. In contrast, working on the enzyme puriﬁed
from A. vinelandii, the F intermediate3 proved to react rapidly with
NO, yielding the oxidized enzyme with nitrite bound at oxidized
heme d [79]. The reaction occurs according to a 1:1 stoichiometry
and proceeds at k = 1.2 ± 0.1  105 M1 s1 at 20 C, i.e., it is even
faster than the same reaction described for CcO (k  1–
2  104 M1 s1), where CuB was suggested to be the primary site
of the reaction [30,31]. In this regard, the results obtained on the
Cu-lacking cytochrome bd suggest that CuB is not essential or possi-
bly not even involved in the reaction. It remains to be established
whether such a reaction (i) involves heme b595, with this heme func-
tionally mimicking CuB in heme–copper oxidases, or (ii) proceeds by
direct reaction of NO with ferryl heme d iron, as documented with
myoglobin and hemoglobin [80,81].
On the contrary, CuB is likely to facilitate the reaction of NO
with ferric heme in the fully oxidized (O) active site of terminal
oxidases. A remarkably different reactivity of the fully oxidized en-
zyme was observed in the Cu-lacking cytochrome bd [82], as com-
pared to CcO [28,29]. In CcO, the reaction of the fully oxidized
enzyme with NO is fast (k = 2.2  105 M1 s1 at 20 C, [29]) and
was proposed to proceed through the following steps: (i) oxidation
of NO to nitrosonium ion (NO+) at CuB, (ii) hydroxylation of NO+ to
nitrous acid/nitrite and, eventually, (iii) nitrite binding to ferric
heme a3 [28]. The reaction is hindered by chloride bound at the
oxidized heme a3-CuB site [29]. In contrast, regardless of chloride
being present, reaction of cytochrome bd in the O state with NO
is much slower (k = 1.5 ± 0.2  102 M1 s1 at 20 C) and does not
yield nitrite-bound enzyme, but rather a nitrosyl adduct (heme
d2+-NO+ or heme d3+-NO, Fig. 4) [82].
It is interesting to notice that, similarly to CcO, cytochrome bd
inhibition by NO is reversible and, accordingly, activity promptly
recovers upon NO depletion [72]. Notably, when NO in solution
is rapidly scavenged (as, for instance, by oxy-hemoglobin to ni-
trate), the reversal of inhibition is much faster in cytochrome bd
than in mammalian CcO under similar experimental conditions3 The metastable F species can be generated in vitro by adding excess H2O2 to the
enzyme [44,78,79].[32]. Under high electron ﬂux conditions, the activity recovery of
CcO is indeed rate-limited by the slow dissociation of NO from fer-
rous heme a3 (k = 0.0035 s1 at 20 C, [32]). Since a similar Fe2+–NO
adduct is likely to form in cytochrome bd upon NO-inhibition, one
may anticipate that the faster activity recovery of the enzyme
should correlate with a faster NO dissociation from ferrous heme
d, compared to CcO. The rate of ligand dissociation from heme d
was thus measured both for the fully reduced (R3-NO) and sin-
gle-electron reduced enzyme (R1-NO) [58], and compared with
available information on CcO (see Table 1). Measurements were
performed by rapidly mixing in a stopped-ﬂow apparatus NO-
bound cytochrome bd with air-equilibrated buffer in the presence
of an excess of oxy-myoglobin. Under these experimental condi-
tions, the NO bound to heme d2+, displaced by O2, dissociates and
rapidly (k = 3–4  107 M1 s1) oxidizes oxy-myoglobin to met-
myoglobin, which thus accumulates at the rate of the ligand disso-
ciation, yielding characteristic absorption changes. At 20 C, NO
dissociates mono-exponentially from R3 and R1 cytochrome bd at
k = 0.133 ± 0.005 and 0.036 ± 0.003 s1, respectively [58] (Table 1).
This result supports the view that the redox state of the b-type
hemes, particularly heme b595, controls the pathway and/or the ki-
netic barrier for ligand dissociation from the active site of cyto-
chrome bd. Notably, the rate of NO dissociation from heme d in
fully reduced cytochrome bd is remarkably higher (about 30 fold)
than the off-rate of the ligand from ferrous heme a3 of CcO under
similar experimental conditions (k = 0.133 s1 vs. k = 0.0035 s1,
[32,58]). Consistently, CO dissociation from fully reduced cyto-
chrome bd is also considerably faster than from the mitochondrial
enzyme (k = 6.0 ± 0.2 s1 vs. k = 0.023 s1 [58,83], see Table 1), in
agreement with the hypothesis that in HCO CuB controls ligand es-
cape from the nearby heme to the bulk phase [84].
The higher koff value for NO measured for cytochrome bd is fully
consistent with the observation that NO-inhibition reverts more
rapidly in the case of cytochrome bd than in CcO [72], a result of
physiological relevance (see below). More recently, the off-rate of
NO from E. coli cytochrome bd was independently measured work-
ing on bacterial cell suspensions [77] and found comparable
(0.163 s1 at 35 C) with that one (0.133 s1 at 20 C) previously
measured with the isolated fully reduced enzyme [58]. Interest-
ingly, the cytochrome bd NO off-rate value is higher than measured
for most hemeproteins. It is comparable to the NO dissociation rate
from soluble guanylate cyclase in the presence of GTP (k = 0.18 s1,
[85]), but lower than the very fast NO off-rate more recently mea-
sured for cd1-type nitrite reductases (up to 200 s1, [86]).
As discussed below, based on the high NO off-rate of bd-type
oxidases, expression of these enzymes, instead of HCOs, was sug-
gested to enhance bacterial tolerance to nitrosative stress, thereby
possibly promoting bacterial pathogenicity [58,87]. The hypothesis
was further supported also more recently [77].
4. Impact on microbial physiology
Cytochrome bd contributes to energy transduction and storage
in the bacterial cell. Its electrogenic4 quinol:O2 oxidoreductase
activity, though not coupled to proton pumping [21], is indeed
linked to the generation of a proton motive force across the mem-
brane that is used for ATP synthesis by the ATP synthase
[20,21,41,52,53]. Apart from its role in cell bioenergetics, however,
cytochrome bd accomplishes a number of additional functions of
physiological relevance for the bacterial cell (Fig. 5). Acting as an
O2-scavenger, the enzyme protects from inactivation of O2-labile
enzymatic functions (such as nitrogenase in diazotrophic bacteria)
(see Refs. [3,5] and references therein) and promotes the4 A non-electrogenic cytochrome bd (called bd-II) was reported in E. coli [88].
Fig. 5. Physiological functions proposed for cytochrome bd.
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ogenic and non-pathogenic bacteria [11,12,14,89]. Moreover, cyto-
chrome bd was reported to expand the physiological range of
environmental O2 tensions at which anoxygenic bacterial photo-
trophs can grow [90]. The enzyme seems also to be implicated in
the response of the bacterial cell to a wide range of stress conditions,
that include low ambient O2 tension, high temperature, high pH,
membrane de-energization by uncouplers and oxidative stress (see
Refs. [3,5] and references therein). Finally, E. coli cytochrome bd-I
was proved to provide the oxidizing power required both by the
DsbA–DsbB system to catalyze disulﬁde bond formation during pro-
tein folding [91] and by protoporphyrinogen IX oxidase (HemG), an
enzyme involved in heme biosynthesis [92].
It is worth mentioning that the expression of cytochrome bd
oxidases was documented in a number of bacterial pathogens, such
as Salmonella [7,10], Mycobacterium tuberculosis [12], Shigella ﬂex-
neri [8], Streptococcus [13], Listeria monocytogenes [15], Brucella
[9,14], members of the strict anaerobe Bacteroides class [11], Kleb-
siella pneumoniae [6], and for some of these pathogens a correlation
between enzyme levels and virulence was observed. Particularly
interesting is the case of Mycobacterium tuberculosis in which a
transient up-regulation of cytochrome bd was observed in vivo in
the transition from acute to chronic infection of mouse lungs, along
with a reduced virulence of a mutant strain defective in the cyto-
chrome bd-associated transporter CydC [12]. In the same study,
in vitro evidence was provided for stimulation of cytochrome bd
expression in M. tuberculosis both under hypoxic conditions and,
interestingly, in response to NO stress. All together, these data
strongly suggest that the bd-type oxidase is required for M. tuber-
culosis adaptation to host immunity, playing a role in pathogenesis.
M. tuberculosis is not the only system in which stimulation of
cytochrome bd expression by NO was documented. NO-induced
expression of cytochrome bd-related genes was also reported for
Staphylococcus aureus [93], Bacillus subtilis [94] and Desulfovibrio
gigas [95]. Moreover, according to a transcriptomic analysis per-
formed on chemostat-cultured E. coli [96], after exposure to NO,
cytochrome bd-I genes proved to be preferentially induced,
whereas unaltered expression of the alternative cytochrome bo3
terminal oxidase was observed. This information nicely matches
the ﬁnding that, in E. coli, compared to the heme–copper bo3-type
oxidase, cytochrome bd is less sensitive to NO-inhibition, i.e., it is
characterized by higher IC50 values for NO, which in turn agrees
with the observation that cytochrome bd-deﬁcient E. coli cells ex-
hibit a higher NO-induced growth inhibition, compared to cyto-
chrome bo3-deﬁcient cells [77].
All this information suggests that cytochrome bd is implicated
in the bacterial response to NO-stress. As originally proposed byour groups [58,87] and later substantiated [77], we think that the
enzyme by virtue of its fast NO dissociation rate confers to bacte-
rial cells a higher resistance to NO. One may indeed anticipate that
the preferential expression of fast NO-dissociating cytochrome bd
over HCOs under NO stress conditions could be beneﬁcial for at
least two reasons: it may (i) reduce the sensitivity of bacterial res-
piration to NO, if the bd enzyme is endowed with higher IC50 values
for NO, and (ii) ensure a faster release of NO-inhibition, i.e., a faster
recovery of respiration, in response to a decline in the NO ﬂux. As
pointed out by Mason et al. [77], the protective role of cytochrome
bd from NO stress is expected to be particularly relevant physiolog-
ically under low O2 tensions. Under these conditions, NO stability
in solution is enhanced and the ability of the bacterial cell to detox-
ify NO is markedly reduced, due to the relatively low afﬁnity of ﬂa-
vohemoglobin for O2 [38], the main aerobic NO-scavenging
enzymatic system in microorganisms. As the sites where bacterial
infection takes place are typically O2-poor, but enriched in the NO
produced as part of the host immune response, a role for cyto-
chrome bd in pathogenesis can be reasonably envisaged. Preferen-
tial expression of cytochrome bd may represent a strategy for
bacterial pathogens to evade the host immune attack based on
NO production.
5. Conclusions
Cytochrome bd oxidases are terminal oxidases conﬁned to the
prokaryotic world, phylogenetically unrelated to the better known
HCOs. Extensive studies on the catalytic intermediates of cyto-
chrome bd and their reactivity towards NO led to the discovery
that the enzyme, though being promptly inhibited by this gaseous
ligand at relatively low concentrations, quickly recovers activity
upon NO removal from solution. The fast recovery has been attrib-
uted to a relatively fast NO dissociation rate from the active site of
the enzyme, that is a peculiarity for a hemeprotein. The structural
features accounting for this unusual behaviour are yet unknown, as
the three-dimensional structure of cytochrome bd is currently not
available. Experimental evidence, however, supports the hypothe-
sis that the peculiar NO reactivity of cytochrome bd likely emerged
during evolution as an adaptive strategy to enable bacterial sur-
vival under NO-stress conditions at low environmental O2 tension.
As conditions of this type are typically created by host immunity to
counteract microbial infection, expression of cytochrome bd
(instead of HCOs) in prokaryotic pathogens is expected to promote
virulence. Consistently, correlations between cytochrome bd
expression levels and bacterial virulence have been reported for
speciﬁc pathogens. Studies on bd-type oxidases, however, need
to be expanded to a wider range of bacteria to conclusively
628 A. Giuffrè et al. / FEBS Letters 586 (2012) 622–629demonstrate whether these respiratory terminal oxidases enhance
pathogenicity by conferring a higher tolerance to nitrosative stress.
These investigations may open new biomedical perspectives. If the
role of cytochrome bd in bacterial pathogenicity is established, the
identiﬁcation of selective inhibitors could indeed pave the way to
interesting pharmacological applications.
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